---
title: "Allmed Medical shareholder Chen Haohua plans to reduce his holdings by no more than 3%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/246092480.md"
description: "According to the Zhitong Finance APP, Allmed Medical announced that shareholder Chen Haohua, who holds 11.81% of the shares, plans to reduce his holdings by no more than 18.5627 million shares (not exceeding 3% of the total share capital) within three months after the announcement date, starting from fifteen trading days after the disclosure"
datetime: "2025-06-25T12:36:01.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/246092480.md)
  - [en](https://longbridge.com/en/news/246092480.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/246092480.md)
generator: "portal-rs"
---

# Allmed Medical shareholder Chen Haohua plans to reduce his holdings by no more than 3%

According to the Zhitong Finance APP, Allmed Medical (002950.SZ) announced that shareholder Chen Haohua, who holds 11.81% of the shares, plans to reduce his holdings by a total of no more than 18.5627 million shares (not exceeding 3% of the total share capital) within three months after the announcement date, starting from the fifteenth trading day

### Related Stocks

- [002950.CN](https://longbridge.com/en/quote/002950.CN.md)

## Related News & Research

- [08:15 ETNow's the Time: Late Summer Is the Best Season For Homebuyers to Score a Deal in These U.S. Metros](https://longbridge.com/en/news/296616885.md)
- [Flexdeal chair Alberto Amaral buys EUR 150,000 in shares](https://longbridge.com/en/news/296250174.md)
- [Chromaviso circadian lighting cuts sick leave up to 21%, InnovationsFonden-backed study shows](https://longbridge.com/en/news/296603687.md)
- [Thales, Systematic partner to boost Danish air defense capabilities](https://longbridge.com/en/news/296363485.md)
- [Invo Fertility highlights retrospective IVF platelet-rich plasma studies at Midwest Reproductive Symposium 2026](https://longbridge.com/en/news/296495699.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**